Company intelligence / Profile preview

Pyrexar Medical

Salt Lake City, Utah, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Pyrexar’s hyperthermia systems (including BSD-2000 series) are commercially available with extensive clinical evidence supporting improved survival and efficacy when combined with radiotherapy and/or chemotherapy in multiple solid tumor types; multi-center trials document significant clinical benefit in various indications[1][3][4].

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Pyrexar Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyrexar Medical.

Explore the full profile